DD
The startup specializes in diagnostic and predictive testing for breast cancer, utilizing advanced biomarker analysis to enhance treatment accuracy. This approach enables patients and healthcare providers to improve disease-free survival rates while minimizing unnecessary treatments and associated toxicity.
Updated 3 months ago
Funding
$470K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in diagnostic and predictive testing for breast cancer, utilizing advanced biomarker analysis to enhance treatment accuracy. This approach enables patients and healthcare providers to improve disease-free survival rates while minimizing unnecessary treatments and associated toxicity.